Skip to main content

187 - References

References

188 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 References

  1. de Leon J, et al. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol Psychiatry 1994; 35:408–419.
  2. Patel JK. Polydipsia, hyponatremia, and water intoxication among psychiatric patients. Hosp Community Psychiatry 1994; 45:1073–1074.
  3. de Leon J. Polydipsia: a study in a long-­term psychiatric unit. Eur Arch Psychiatry Clin Neurosci 2003; 253:37–39.
  4. Siegel AJ, et al. Primary and drug-­induced disorders of water homeostasis in psychiatric patients: principles of diagnosis and management. Harv Rev Psychiatry 1998; 6:190–200.
  5. Kirino S, et  al. Relationship between polydipsia and antipsychotics: a systematic review of clinical studies and case reports. Prog Neuropsychopharmacol Biol Psychiatry 2020; 96:109756.
  6. Siegler EL, et al. Risk factors for the development of hyponatremia in psychiatric inpatients. Arch Intern Med 1995; 155:953–957.
  7. Madhusoodanan S, et al. Hyponatraemia associated with psychotropic medications: a review of the literature and spontaneous reports. Adverse Drug React Toxicol Rev 2002; 21:17–29.
  8. Takeda K, et al. Analysis of the frequency and onset time of hyponatremia/syndrome of inappropriate antidiuretic hormone induced by antidepressants or antipsychotics. Ann Pharmacother 2022; 56:303–308.
  9. Bachu K, et al. Aripiprazole-­induced syndrome of inappropriate antidiuretic hormone secretion (SIADH). Am J Ther 2006; 13:370–372.
  10. Dudeja SJ, et al. Olanzapine induced hyponatraemia. Ulster Med J 2010; 79:104–105.
  11. Yam FK, et  al. Syndrome of inappropriate antidiuretic hormone associated with aripiprazole. Am J Health Syst Pharm 2013; 70:2110–2114.
  12. Kaur J, et al. Paliperidone inducing concomitantly syndrome of inappropriate antidiuretic hormone, neuroleptic malignant syndrome, and rhabdomyolysis. Case Rep Crit Care 2016; 2016:2587963.
  13. Lin MW, et  al. Aripiprazole-­related hyponatremia and consequent valproic acid-­related hyperammonemia in one patient. Aust N Z J Psychiatry 2017; 51:296–297.
  14. Koufakis T. Quetiapine-­induced syndrome of inappropriate secretion of antidiuretic hormone. Case Rep Psychiatry 2016; 2016:4803132.
  15. Chen LC, et al. Polydipsia, hyponatremia and rhabdomyolysis in schizophrenia: a case report. World J Psychiatry 2014; 4:150–152.
  16. Bakhla AK, et al. A suspected case of olanzapine induced hyponatremia. Indian J Pharmacol 2014; 46:441–442.
  17. Kane JM, et al. Efficacy and safety of cariprazine in acute exacerbation of schizophrenia: results from an international, phase III clinical trial. J Clin Psychopharmacol 2015; 35:367–373.
  18. Tibrewal P, et al. Paliperidone-­induced hyponatremia. Prim Care Companion CNS Disord 2017; 19:16l02088.
  19. McNally MA, et al. Olanzapine-­induced hyponatremia presenting with seizure requiring intensive care unit admission. Cureus 2020; 12:e8212.
  20. Sachdeva A, et al. Hyponatremia with olanzapine: a suspected association. Shanghai Arch Psychiatry 2017; 29:177–179.
  21. Kumar PNS, et  al. Hyponatremia secondary to SIADH in a schizophrenic patient treated with Quetiapine. Asian J Psychiatr 2018; 35:89–90.
  22. Mazhar F, et al. Paliperidone-­associated hyponatremia: report of a fatal case with analysis of cases reported in the literature and to the US Food and Drug Administration Adverse Event Reporting System. J Clin Psychopharmacol 2020; 40:202–205.
  23. Chowdhury W, et al. Management of persistent hyponatremia induced by long-­acting injectable risperidone therapy. Cureus 2018; 10:e2657.
  24. Anil SS, et al. A case report of rapid-­onset hyponatremia induced by low-­dose olanzapine. J Family Med Prim Care 2017; 6:878–880.
  25. Kang SG, et al. Addendum: low-­dose quetiapine-­induced syndrome of inappropriate antidiuretic hormone in a patient with traumatic brain syndrome. Clin Psychopharmacol Neurosci 2021; 19:179.
  26. Aruachán S, et al. Hyponatraemia associated with the use of quetiapine: case report. Rev Colomb Psiquiatr 2020; 49:297–300. Cause of hyponatraemia Antipsychotic drugs implicated Treatment SIADH (serum osmolality low; urine osmolality relatively high) All antipsychotic drugs ■ ■If mild, fluid restriction with careful monitoring of serum sodium. Refer urgently to specialist medical care if Na <125mmol/L. ■ ■Dose reduction of the antipsychotic has been suggested45 but evidence to support this strategy is lacking ■ ■Switching to a different antipsychotic drug. There are insufficient data available to guide choice. Be aware that cross-­sensitivity may occur (the individual may be predisposed overall and the choice of drug unimportant). ■ ■Consider demeclocycline (see formal prescribing information for details) ■ ■Lithium may be effective7 but is a potentially toxic drug (and hyponatraemia predisposes to lithium toxicity) Table 1.42  (Continued )

Schizophrenia and related psychoses CHAPTER 1 27. Zhu X, et al. Rhabdomyolysis and elevated liver enzymes after rapid correction of hyponatremia due to pneumonia and concurrent use of aripiprazole: a case report. Aust N Z J Psychiatry 2018; 52:206. 28. Mc Donald D, et al. Extreme hyponatraemia due to primary polydipsia and quetiapine-­induced SIAD. Endocrinol Diabetes Metab Case Rep 2021; 2021:21-­0028. 29. Younes N, et al. Olanzapine induced hyponatremia and rhabdomyolysis. Clin Case Rep 2023; 11:e5951. 30. Soenarti S, et al. Chlorpromazine-­induced severe hyponatremia in 66 years old patient. Acta Med Indones 2023; 55:444–448. 31. Meulendijks D, et al. Antipsychotic-­induced hyponatraemia: a systematic review of the published evidence. Drug Saf 2010; 33:101–114. 32. Mannesse CK, et al. Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-­control study in VigiBase. Drug Saf 2010; 33:569–578. 33. Falhammar H, et al. Antipsychotics and severe hyponatremia: a Swedish population-­based case–control study. Eur J Intern Med 2019; 60:71–77. 34. Mazhar F, et al. Hyponatremia following antipsychotic treatment: in silico pharmacodynamics analysis of spontaneous reports from the US Food and Drug Administration Adverse Event Reporting System Database and an updated systematic review. Int J Neuropsychopharmacol 2021; 24:477–489. 35. Atsariyasing W, et al. A systematic review of the ability of urine concentration to distinguish antipsychotic-­ from psychosis-­induced hyponatremia. Psychiatry Res 2014; 217:129–133. 36. Letmaier M, et  al. Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme. Int J Neuropsychopharmacol 2012; 15:739–748. 37. Serrano A, et al. Safety of long-­term clozapine administration. Frequency of cardiomyopathy and hyponatraemia: two cross-­sectional, naturalistic studies. Aust N Z J Psychiatry 2014; 48:183–192. 38. Sarma S, et al. Severe hyponatraemia associated with desmopressin nasal spray to treat clozapine-­induced nocturnal enuresis. Aust N Z J Psychiatry 2005; 39:949. 39. Yang HJ, et  al. Antipsychotic use is a risk factor for hyponatremia in patients with schizophrenia: a 15-­year follow-­up study. Psychopharmacology 2017; 234:869–876. 40. Adelakun AA, et al. Severe syndrome of inappropriate antidiuretic hormone secretion (SIADH) following the initiation of valbenazine for tardive dyskinesia: a case report. Cureus 2024; 16:e58493. 41. Shepshelovich D, et al. Medication-­induced SIADH: distribution and characterization according to medication class. Br J Clin Pharmacol 2017; 83:1801–1807. 42. Yamamoto Y, et al. Prevalence and risk factors for hyponatremia in adult epilepsy patients: large-­scale cross-­sectional cohort study. Seizure 2019; 73:26–30. 43. Fabrazzo M, et al. The unmasking of hidden severe hyponatremia after long-­term combination therapy in exacerbated bipolar patients: a case series. Int Clin Psychopharmacol 2019; 34:206–210. 44. Seifert J, et al. Psychotropic drug-­induced hyponatremia: results from a drug surveillance program—an update. J Neural Transm (Vienna) 2021; 128:1249–1264. 45. Pinkhasov A, et al. Management of SIADH-­related hyponatremia due to psychotropic medications –­ an expert consensus from the Association of Medicine and Psychiatry. J Psychosom Res 2021; 151:110654. 46. Josiassen RC, et al. Tolvaptan: a new tool for the effective treatment of hyponatremia in psychotic disorders. Expert Opin Pharmacother 2010; 11:637–648. 47. Decaux G, et al. Non-­peptide arginine-­vasopressin antagonists: the vaptans. Lancet 2008; 371:1624–1632. 48. Bhatia MS, et al. Psychogenic polydipsia –­ management challenges. Shanghai Arch Psychiatry 2017; 29:180–183. 49. Zaidi AN. Rhabdomyolysis after correction of hyponatremia in psychogenic polydipsia possibly complicated by ziprasidone. Ann Pharmacother 2005; 39:1726–1731. 50. Canuso CM, et al. Clozapine restores water balance in schizophrenic patients with polydipsia-­hyponatremia syndrome. J Neuropsychiatry Clin Neurosci 1999; 11:86–90. 51. Fujimoto M, et al. Clozapine improved the syndrome of inappropriate antidiuretic hormone secretion in a patient with treatment-­resistant schizophrenia. Psychiatry Clin Neurosci 2016; 70:469. 52. Spears NM, et al. Clozapine treatment in polydipsia and intermittent hyponatremia. J Clin Psychiatry 1996; 57:123–128. 53. Littrell KH, et al. Effects of olanzapine on polydipsia and intermittent hyponatremia. J Clin Psychiatry 1997; 58:549. 54. Kawai N, et  al. Risperidone failed to improve polydipsia-­hyponatremia of the schizophrenic patients. Psychiatry Clin Neurosci 2002; 56:107–110. 55. Montgomery JH, et al. Adjunctive quetiapine treatment of the polydipsia, intermittent hyponatremia, and psychosis syndrome: a case report. J Clin Psychiatry 2003; 64:339–341. 56. Canuso CM, et al. Does minimizing neuroleptic dosage influence hyponatremia? Psychiatry Res 1996; 63:227–229. 57. Nixon RA, et al. Demeclocycline in the prophylaxis of self-­induced water intoxication. Am J Psychiatry 1982; 139:828–830. 58. Vieweg WV, et al. The use of demeclocycline in the treatment of patients with psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome). Psychiatr Q 1988; 59:62–68. 59. Srinivasan S, et al. Psychogenic polydipsia. 2022 (last updated April 2024, last checked May 2024); https://bestpractice.bmj.com/topics/ en-­gb/865. 60. Walter-­Ryan WG. Water intoxication, demeclocycline, and antidiuretic hormone. Am J Psychiatry 1983; 140:815. 61. Alexander RC, et al. A double blind, placebo-­controlled trial of demeclocycline treatment of polydipsia-­hyponatremia in chronically psychotic patients. Biol Psychiatry 1991; 30:417–420. 62. Havens TH, et al. Non-­antipsychotic pharmacotherapy of psychogenic polydipsia: a systematic review. J Psychosom Res 2021; 152:110674. 63. Ahmed SE, et al. Acetazolamide: treatment of psychogenic polydipsia. Cureus 2017; 9:e1553. 64. Takagi S, et al. Treatment of psychogenic polydipsia with acetazolamide: a report of 5 cases. Clin Neuropharmacol 2011; 34:5–7.

No comments to display

Back to top